Akers Biosciences Inc (AKR)

 

Latest News

Issue of Equity

RNS Number: 7278H Akers Biosciences, Inc. 09 June 2017 June 9, 2017 This announcement contains inside information Akers Biosciences, Inc. Issue of Equity Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, has received further conversion notices from warrant holders to ...

Akers Biosciences revenue down

Akers Biosciences revealed that total revenue fell to $667,250 in the first quarter of 2017, down from $738,023 in the first qu...

1st Quarter Results

RNS Number: 1984F Akers Biosciences, Inc. 16 May 2017 May 16, 2017 This announcement contains inside information Akers Biosciences, Inc. Financial Results for the First Quarter Ended March 31, 2017 Significant Cost Reductions and Progress Towards Breakeven Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers", "Akers Bio" or the "Company"), a d...

Akers Biosciences schedules interims

Akers Biosciences has said it will publish its financial results in the United Kingdom for the three months ended March 31...

All News

DateHeadlineSource
09-06-17Issue of EquityRNS
16-05-17Akers Biosciences revenue down StockMarketWire
16-05-171st Quarter ResultsRNS
12-05-17Akers Biosciences schedules interimsStockMarketWire
12-05-17Notice of Q1 ResultsRNS
05-05-17Issue of EquityRNS
24-04-17Issue of EquityRNS
11-04-17Holding(s) in CompanyRNS
11-04-17Akers Bio revenues up 40%StockMarketWire
11-04-17Final ResultsRNS
10-04-17Notice of ResultsRNS
10-04-17Issue of EquityRNS
10-04-17Akers Bio marketing HIT rapid test in Puerto RicoStockMarketWire
10-04-17Heparin PF4 Rapid Test in Puerto RicoRNS
07-04-17Akers Bio warrants exercised StockMarketWire
06-04-17Issue of EquityRNS
04-04-17Issue of EquityRNS
31-03-17FTSE falls on miners, financials as Old Mutual suffersStockMarketWire
31-03-17Issue of EquityRNS
30-03-17Detailed Year-end Trading UpdateRNS
29-03-17Notice of ResultsRNS
28-03-17Initial Order for Rapid Cholesterol Self-testRNS
16-02-17Akers Bio granted US patent StockMarketWire
16-02-17US Patent for Akers Wellness Tests CartridgeRNS
01-02-17Akers Bio revenues up 66%StockMarketWire
01-02-17Trading UpdateRNS
13-01-17Akers Bio offering increased StockMarketWire
13-01-17Issue of EquityRNS
10-01-17Issue of EquityRNS
09-01-17Supplement to Form S-3 Registration StatementRNS
20-12-16Akers Bio resolutions passed at AGMStockMarketWire
19-12-16Result of AGMRNS
19-12-16Agreement with GNYHA for PIFA Heparin PF4 TestRNS
01-12-16US Distribution Agreement: Cholesterol Self-testRNS
28-11-16Akers Bio completes BreathScan DKA trial StockMarketWire
28-11-16Clinical Trial for BreathScan DKA CompletedRNS
14-11-16Notice of AGMRNS
14-11-16Akers Bio revenues up 262%StockMarketWire
14-11-16Akers Bio revenues up 262%StockMarketWire
14-11-163rd Quarter ResultsRNS

RSS feeds

  • Editorial news feed for LSE:AKR Editorial
  • Regulatory news feed for LSE:AKR Regulatory